AC
TPTX

Aaron Cowen’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Aaron Cowen’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-122,994
Closed -$9.6M – 141
2021
Q2 		$9.6M Buy
+122,994
New +$9.09M 0.14% 82
2020
Q4 		– Sell
-79,331
Closed -$6.93M – 133
2020
Q3 		$6.93M Buy
79,331
+54,100
+214% +$3.77M 0.12% 61
2020
Q2 		$1.63M Sell
25,231
-7,069
-22% -$408K 0.04% 76
2020
Q1 		$1.44M Buy
+32,300
New +$1.72M 0.04% 43

Other funds holding TPTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Aaron Cowen's TPTX Position: Q3 2021 in Review

Aaron Cowen sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2021, closing a stake of 122,994 shares — an estimated $9.6M sold.

Aaron Cowen first reported a position in TPTX in Q1 2020 and held it in 4 quarters. The position peaked at $9.6M in Q2 2021. 190 funds tracked by Wall St. Rank hold TPTX as of Q3 2021.

  • Aaron Cowen reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Aaron Cowen sold 122,994 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $9.6M.
  • Aaron Cowen first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Aaron Cowen's Turning Point Therapeutics, Inc. Common Stock position peaked at $9.6M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Suvretta Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.